Ligand Pharmaceuticals Incorporated
ARIA INTELLIGENCE BRIEF
Congressional disclosure records for this Health Care sector security show a single member, Gil Cisneros, accounting for all four disclosed trades — each a purchase, with no sales recorded — spanning January 5, 2026 through May 29, 2026. The activity is entirely one-sided in direction, though it reflects only one member's filings and no bipartisan co-trading clusters are recorded for this ticker. Separately, two executive-branch officials have disclosed three transactions in the same security in public filings, though the closest congressional and executive purchases are 180 days apart, outside the 90-day proximity window.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
4
BUYS
4
SELLS
0
MEMBERS
1
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+7.56%
vs SPY benchmark
LGND timeline6 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Stephens, Warren | Jul 24, 25 | SELL | $500K–$1.0M | |
Stephens, Warren | Jul 9, 25 | BUY | $1K–$15K | |
Gradison, Andrew Acting Assistant Secretary | Mar 5, 25 | SELL | $1K–$15K |
4 trades
Congressional trading data from STOCK Act filings. Not investment advice.